HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 205-216 of 1,979
Drug study icon
CompletedNCT00154323

Oxcarbazepine 300-1200 mg/Day for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Oxcarbazepine for people with bipolarity.

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Novartis
Device study icon
CompletedNCT01446406

The MONARCA Project (MONitoring, treAtment and pRediCtion of Bipolarity Episodes)

Official study title

Electronic Daily Self-monitoring of Subjective and Objective Symptoms in Bipolar Disorder - The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)

This study has finished and is no longer accepting participants.

In Copenhagen
BipolarityDevice studyAges 18–60
Countries
Denmark
Sponsor
Psychiatric Centre Rigshospitalet
Drug study icon
CompletedNCT01575561

Effectiveness of lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex in Bipolarity

Official study title

A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
BipolarityMedication studyAges 18+
Countries
United States, France, Argentina, + 9 others
Sponsor
Sumitomo Pharma America, Inc.
Other study type icon
CompletedNCT02970721

Use of Psychotropic Medications Among Pregnant Women With Bipolarity

Official study title

Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder: Patterns, Determinants, and Impact on Perinatal Outcomes

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityObservational studyAges 15–50
Countries
Sponsor
Western University, Canada
Drug study icon
CompletedNCT03259555

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes Associated With Bipolarity type I

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Poland, + 1 other
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
TerminatedNCT00732251

Allopurinol Maintenance Study for Bipolarity

Official study title

An Open Label, Naturalistic Study With Allopurinol Augmentation for Prevention of Mania in Bipolar Disorder

This study ended early.

In Los Angeles
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
Cedars-Sinai Medical Center
Drug study icon
CompletedNCT00448578

Seroquel and Lithium for manic episodes in bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Quetiapine Fumarate for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
BipolarityMedication studyAges 18–65
Countries
China
Sponsor
AstraZeneca

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.